A detailed history of Mediolanum International Funds LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Mediolanum International Funds LTD holds 828,479 shares of NVO stock, worth $87.2 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
828,479
Holding current value
$87.2 Million
% of portfolio
1.37%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$119.07 - $145.42 $98.6 Million - $120 Million
828,479 New
828,479 $98.8 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.